...
首页> 外文期刊>Nephrology. >Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.
【24h】

Histopathological changes and tumour necrosis factor-alpha, transforming growth factor-beta and tenascin expression in patients with primary type I membranoproliferative glomerulonephritis in remission.

机译:缓解的原发性I型膜增生性肾小球肾炎患者的组织病理学变化和肿瘤坏死因子-α,转化生长因子-β和肌腱蛋白的表达。

获取原文
获取原文并翻译 | 示例

摘要

AIM: Primary type I membranoproliferative glomerulonephritis (MPGN) is a rare cause of glomerular disease with a high relapse rate and poor prognosis. The aim of this study was: (i) to evaluate the histopathological findings associated with remission; and (ii) to document the possible clinical and histopathological factors predicting relapses. METHODS: Eleven type I MPGN patients (five men, six women; mean age, 38.8+/-13.5 years) who were in remission for at least 1 year after the cessation of immunosuppressive drugs were re-biopsied. The intensity of immunostaining for tumor necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1, and tenascin was graded from 0 (no staining) to 3+ (maximum staining). RESULTS: Mean baseline mesangial cellularity score and tubulointerstitial infiltration score were reduced and mesangial matrix expansion score was increased at protocol re-biopsies compared to baseline. The glomerular and tubulointerstitial staining scores for TGF-beta1 and tenascin were higher than that of baseline. Reduced tubulointerstitial TNF-alpha expression was found in re-biopsy specimens compared to baseline. Patients have been followed for a mean time of 51.5+/-22.2 months after the protocol biopsy. Eight patients had a relapse. Mesangial cellularity score and glomerular tenascin expression at re-biopsy specimens were higher in relapsed patients compared to those without a relapse. CONCLUSION: Our study shows that mesangial cellularity and tubulointerstitial cell infiltration are reducing whereas mesangial matrix expansion, glomerular and tubulointerstitial TGF-beta1 and tenascin expression are increasing with remission. The higher mesangial cell proliferation and glomerular tenascin scores in remission are associated with the development of relapse.
机译:目的:原发性I型膜增生性肾小球肾炎(MPGN)是一种罕见的肾小球疾病病因,复发率高且预后差。这项研究的目的是:(i)评价与缓解相关的组织病理学发现; (ii)记录预测复发的可能的临床和组织病理学因素。方法:对11例I型MPGN患者(5例男性,6例女性;平均年龄38.8 +/- 13.5岁)进行了活检,这些患者在停止免疫抑制药物后至少缓解了1年。肿瘤坏死因子(TNF)-α,转化生长因子(TGF)-β1和腱糖的免疫染色强度从0(无染色)至3+(最大染色)分级。结果:与基线相比,在方案活检中平均基线肾小球膜细胞性评分和肾小管间质浸润评分降低,肾小球膜基质扩张评分提高。 TGF-β1和腱糖的肾小球和肾小管间质染色得分均高于基线。与基线相比,再活检标本中发现肾小管间质TNF-α表达降低。方案活检后平均随访时间为51.5 +/- 22.2个月。 8例患者复发。与没有复发的患者相比,复发患者的肾小球系膜细胞评分和肾小球腱生蛋白表达更高。结论:我们的研究表明肾小球系膜细胞和肾小管间质细胞浸润减少,而肾小球系膜基质扩张,肾小球和肾小管间质TGF-β1和腱糖蛋白表达随缓解而增加。缓解中系膜细胞增生和肾小球肌腱蛋白评分与复发的发展有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号